Detalles de la búsqueda
1.
Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial.
Brain
; 147(3): 849-857, 2024 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37936330
2.
Effects of cannabidiol and Δ9-tetrahydrocannabinol on cytochrome P450 enzymes: a systematic review.
Drug Metab Rev
; 56(2): 164-174, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38655747
3.
Impact of Baseline Anxiety on Well-being in People with Post-COVID-19 Condition: A Secondary Analysis.
CNS Spectr
; 29(2): 150-154, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38453677
4.
Impact of vortioxetine on psychosocial functioning moderated by symptoms of fatigue in post-COVID-19 condition: a secondary analysis.
Neurol Sci
; 45(4): 1335-1342, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38321333
5.
Sex Differences in Outcomes after Endovascular Thrombectomy for Patients with Acute Ischemic Stroke.
Eur Neurol
; 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38797167
6.
Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetine.
Ann Gen Psychiatry
; 23(1): 10, 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38424537
7.
Impact of elevated body mass index (BMI) on cognitive functioning and inflammation in persons with post-COVID-19 condition: a secondary analysis.
Acta Neuropsychiatr
; : 1-7, 2024 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38605630
8.
Neuroanatomical predictors of problematic alcohol consumption in adolescents: a systematic review of longitudinal studies.
Alcohol Alcohol
; 58(5): 455-471, 2023 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37553844
9.
The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS).
Expert Opin Drug Saf
; 23(1): 47-55, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38087976
10.
The association between ketamine and esketamine with alcohol and substance misuse: Reports to the Food and Drug Administration adverse event reporting system (FAERS).
J Affect Disord
; 360: 421-426, 2024 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38795777
11.
The association between ketamine and esketamine and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS).
Expert Opin Drug Saf
; 2024 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38884147
12.
The psychological factors mediating/moderating the association between body-image disturbance and depression: A systematic review.
Psych J
; 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38725387
13.
Psychotropic Drug-Related Weight Gain and Its Treatment.
Am J Psychiatry
; 181(1): 26-38, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38161305
14.
The role of KCNQ channel activators in management of major depressive disorder.
J Affect Disord
; 359: 364-372, 2024 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38772507
15.
Prospective, comparative, pilot study of maintenance treatment in comorbid bipolar disorders with post-traumatic stress disorder.
Int Clin Psychopharmacol
; 2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38381901
16.
Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis.
J Affect Disord
; 356: 753-762, 2024 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38636712
17.
Association between dual orexin receptor antagonists (DORAs) and suicidality: reports to the United States Food and Drug Administration Adverse Event Reporting System (FAERS).
Expert Opin Drug Saf
; : 1-5, 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38804896
18.
Subjective and Objective Measures of Cognitive Function are Correlated in Persons with Post-COVID-19 Condition: A Secondary Analysis of a Randomized Controlled Trial.
medRxiv
; 2024 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38562707
19.
Greater Role of Cognitive Impairment Over Fatigue in Post-COVID-19 Quality of Life: A Post-Hoc Analysis of a Randomized Controlled Trial.
medRxiv
; 2024 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38562760
20.
Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.
J Affect Disord
; 355: 342-354, 2024 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38570038